Lincoln Pharmaceuticals Limited (NSE:LINCOLN)

Lincoln Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Lincoln Pharmaceuticals had annual revenue of 6.71B INR with 7.67% growth. Lincoln Pharmaceuticals had revenue of 1.87B in the quarter ending March 31, 2026, with 11.35% growth.

• Revenue: 6.71B
• Revenue Growth: +7.67%
• P/S Ratio: 1.83
• Revenue / Employee: 3.62M
• Employees: 1,853
• Market Cap: 12.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	6.71B	478.00M	7.67%
Mar 31, 2025	6.23B	426.81M	7.35%
Mar 31, 2024	5.81B	702.41M	13.76%
Mar 31, 2023	5.10B	381.86M	8.09%
Mar 31, 2022	4.72B	479.38M	11.30%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 19, 2026

Data Sources Report a data error